NCT02687217

Brief Summary

The study evaluates the role of supplemental hyper-oxygenation given perioperatively on wound site infection after appendectomy. Half of the patients received ≥50% oxygen and half of them received no oxygen during the surgical procedure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2011

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 22, 2016

Completed
2 months until next milestone

Results Posted

Study results publicly available

May 6, 2016

Completed
Last Updated

May 6, 2016

Status Verified

April 1, 2016

Enrollment Period

1.3 years

First QC Date

February 9, 2016

Results QC Date

March 2, 2016

Last Update Submit

April 2, 2016

Conditions

Keywords

PerioperativeHyperoxygenationWound Site InfectionAppendicitis

Outcome Measures

Primary Outcomes (1)

  • ASEPSIS Score

    ASEPSIS score- Additional treatment; Serous discharge; Erythema; Purulent exudate; Separation of deep tissues; Isolation of bacteria; and Stay. A daily score of 20 or more considered evidence of infection. Category of infection: Total score of 0-10 satisfactory healing; 11-20 disturbance of healing; 21-30 minor wound infection; 31-40 moderate wound infection; \> 40 severe wound infection.

    14 days

Secondary Outcomes (2)

  • Number of Patients Requiring Additional Investigations

    14 days

  • Number of Patients Requiring Additional Treatment

    14 days

Study Arms (2)

Group A: Control

NO INTERVENTION

Group A: Control- Received no supplemental oxygen throughout the surgery and received oxygen at 4l/min. in 2hrs postoperatively

Group B: Test

EXPERIMENTAL

Group B: Test- Received hyperoxygenation more than or equal to 50% throughout the surgery and received oxygen at 6l/min. upto 2 hrs postoperatively.

Drug: oxygen

Interventions

oxygenDRUG

Hyperoxygenation ≥50% of oxygen by mask(non-rebreathing) was given through out the surgery. Received 6L/min of oxygen through venturimask upto 2 hours in post operative period. Hyperoxygenation refers to provision of ≥50% of oxygen by mask(non-rebreathing) through out the surgery.

Group B: Test

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis or Radiological diagnosis of acute appendicitis.
  • Appendectomy through the Mc Burney incision.

You may not qualify if:

  • Patients with chronic obstructive pulmonary diseases.
  • Immunodeficiency disease.
  • Patients requiring midline incision.
  • Patients requiring general anaesthesia after failure of spinal anaesthesia.
  • Patients requiring higher oxygen in perioperative period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Wound InfectionAppendicitis

Interventions

Oxygen

Condition Hierarchy (Ancestors)

InfectionsIntraabdominal InfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Limitations and Caveats

The study included a small sample size of 60 patients, randomized into equal study group and control group as the time limit restrictions of 12- 15 months as prescribed by the residency programme.

Results Point of Contact

Title
Dr. Swati Sattavan
Organization
Lady Hardinge Medical College and associated Hospitals

Study Officials

  • Swati Sattavan, M.S.

    Lady Hardinge Medical College and Associated Hospitals

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Resident

Study Record Dates

First Submitted

February 9, 2016

First Posted

February 22, 2016

Study Start

November 1, 2011

Primary Completion

March 1, 2013

Study Completion

May 1, 2013

Last Updated

May 6, 2016

Results First Posted

May 6, 2016

Record last verified: 2016-04